Feed the Gut, Cautiously: Nutrition Timing in a Patient Still on Vasopressors
A critically ill man on downtrending norepinephrine support needs a nutrition decision that neither reflexively follows EPaNIC's case against early parenteral nutrition nor ignores the real bowel-perfusion risk his vasopressor dose still carries.
Rudy F., a 66-year-old retired locksmith, is on hospital day three of an ICU admission for septic shock following a perforated diverticulitis, now post-operative after a Hartmann's procedure, and has not eaten anything by mouth or through a tube since the day he arrived. Three days is not a neutral interval: guideline targets for initiating enteral nutrition in critical illness are measured in the first twenty-four to forty-eight hours, so the question in front of the team is no longer whether to start early but how much of that window has already been spent, and on what grounds it was spent. His daughter, who has barely left the waiting room since his admission, asked the team directly this morning whether 'not feeding him' was making him weaker — a question that turns out to have a more complicated answer than either 'yes, start feeding him now' or 'no, it's fine to wait' would suggest, and one that deserved a fuller answer than a hallway reassurance could give her.
His norepinephrine requirement peaked at 0.35 mcg/kg/min on hospital day one and has been trending down steadily since, now at 0.12 mcg/kg/min over the past twelve hours — real, meaningful improvement, but not yet off vasopressors entirely. His lactate says the same thing from another direction, down from a peak of 5.8 to 2.1, and his abdomen is soft and undistended with bowel sounds present — three separate readings all pointing at a gut better perfused today than it was on arrival, none of them establishing that it is perfused enough. His kidneys point the same way and with the same caveat: an acute injury that is improving without replacement therapy is evidence that end-organ perfusion is recovering, and the kidney is not the bowel. That convergence matters directly to the nutrition decision in front of the team, because the two major trials that shaped current practice on this question don't cleanly resolve his specific situation: EPaNIC found early parenteral nutrition in a broad critically ill population caused more harm than benefit, while a real, separate physiologic concern — reduced gut perfusion under ongoing vasopressor support — argues for caution about pushing enteral feeding aggressively into a bowel that may not yet be receiving normal blood flow.
At the bedside, a downtrending pressor and a real perfusion question
I'd start enteral feeding through a post-pyloric tube rather than parenteral nutrition, even with him on moderate-dose norepinephrine. The EPaNIC trial randomized over 4,600 critically ill adults to early versus withheld-until-day-8 parenteral nutrition and found early PN was associated with more infections, longer ICU stay, and no mortality benefit — the opposite of what early, aggressive nutritional support was assumed to produce at the time. Enteral nutrition, even at trophic rates, is the current default whenever the gut can plausibly be used.
I'd flag the actual reason his case isn't a clean match to that trial population: EPaNIC didn't specifically isolate patients on significant vasopressor support with real concern for bowel perfusion, and enteral feeding into a gut that's under-perfused carries a genuine, mechanism-based risk of nonocclusive bowel ischemia, a rare but serious complication most concerning at higher vasopressor doses. His norepinephrine requirement has been trending down, not up, over the past twelve hours, which matters directly to how much weight that concern should carry today versus yesterday.
The CALORIES trial found no real difference between early parenteral and early enteral nutrition in a broader critically ill population where enteral feeding wasn't specifically contraindicated, which supports the critical care physician's default, but it doesn't specifically resolve the vasopressor-dose question his case actually raises.
That's a fair, specific distinction, and it changes what I'd actually order today: start enteral nutrition at trophic rate rather than full-target rate, given his still-meaningful, if downtrending, vasopressor requirement, and hold full-target advancement until he's been off pressors entirely for at least twenty-four hours. That's a real compromise between the EPaNIC-driven default and the pharmacologist's specific bowel-perfusion concern, not a decision to just pick one trial over the other.
Agreed: start enteral nutrition today at a trophic, reduced rate through a post-pyloric tube, rather than either withholding nutrition further or starting parenteral nutrition by default, with advancement to full-target rate held until he has been off vasopressor support entirely for at least 24 hours.
Not fully agreed: how closely to monitor for early signs of bowel ischemia during the trophic-rate period, and what threshold of abdominal exam change or lactate rise should trigger stopping enteral feeding altogether. The pharmacologist wanted a lower, more sensitive threshold given the mechanism concern that motivated the trophic-rate compromise in the first place; the critical care physician preferred relying on the same clinical exam parameters already used for every post-operative ICU patient, worried that an overly sensitive threshold would trigger unnecessary interruptions in a patient who is, by every other measure, improving. That specific threshold was left to the bedside team's ongoing judgment rather than fixed in advance.